Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Ryan Lynch

See Remarks at Crescent Biopharma, Inc. (CBIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $13K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 18SEC CBIOCrescent Biopharma, Inc. Sell Plan 24013,631 held (−2%) $17.90 $4K -33.9%
Jun 23SEC CBIOCrescent Biopharma, Inc. Sell Plan 46513,871 held (−3%) $17.99 $8K -34.2%
  • Sell

    See Remarks Ryan Lynch sold $4K of CBIO at $17.90 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Ryan Lynch sold $8K of CBIO at $17.99 — pre-scheduled 10b5-1 plan sale.